蔓越莓对链脲霉素诱导的小鼠糖尿病肾病的肾保护作用

Q2 Pharmacology, Toxicology and Pharmaceutics Drug metabolism and personalized therapy Pub Date : 2024-03-12 eCollection Date: 2024-03-01 DOI:10.1515/dmpt-2023-0092
Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh
{"title":"蔓越莓对链脲霉素诱导的小鼠糖尿病肾病的肾保护作用","authors":"Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh","doi":"10.1515/dmpt-2023-0092","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Diabetic nephropathy is a chief reason of mortality particularly in individuals with renal dysfunction. The current research was aimed to assess the nephroprotective portion of <i>Vaccinium oxycoccos</i> toward mice diabetic nephropathy induced by streptozotocin (STZ). <i>V. oxycoccos</i> was purchased and used for hydroalcoholic extraction.</p><p><strong>Methods: </strong>Sixty male mice were subjected to STZ-intraperitoneal injection (45 mg/kg). After diabetes induction, mice were divided into five groups of diabetic control (received only STZ), non-diabetic control (received only citrate buffer), two <i>V. oxycoccos</i> treatment (received <i>V. oxycoccos</i> extract (200 and 400 mg/kg) oral daily by gavage), and metformin treatment (received metformin (500 mg/kg) oral daily by gavage). Glucose and weight of mice were checked weekly.</p><p><strong>Results: </strong>After 28 days, the effect of <i>V. oxycoccos</i> extract on serum and urine parameters were assessed. STZ caused significant decreased in the mice body weight. Mice treated with the <i>V. oxycoccos</i> (400 mg/kg) harbored the lowest weight loss at day 28 (70.2±1.38 g). STZ caused significant increase in the mice FBS. Mice treated with the <i>V. oxycoccos</i> (400 mg/kg) harbored the lowest FBS at day 28 (189.2±1.20 mg/dL). Treatment of mice with <i>V. oxycoccos</i> (400 mg/kg) caused the lowest increase in the levels of cholesterol, HbA<sub>1c</sub> and triglycerides compared to the diabetic control mice. Compared to the diabetic control group, mice treated with <i>V. oxycoccos</i> (400 mg/kg) had the highest HDL, insulin, SOD, and GSH (p<0.05). The lowest serum BUN, CR, and UR were found in mice treated with <i>V. oxycoccos</i> (400 mg/kg). Anti-inflammatory effects of <i>V. oxycoccos</i> (400 mg/kg) was shown by the lowest TNF-α, IL-6, and TGF-β1 concentration in mice treated with <i>V. oxycoccos</i> (400 mg/kg).</p><p><strong>Conclusions: </strong>The current study disclosed that treatment with <i>V. oxycoccos</i> resulted in substantial development in the serum and urine parameters and also antioxidant and anti-inflammatory response of STZ-induced diabetic mice.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Nephroprotective effect of cranberry (<i>Vaccinium oxycoccos</i>) in streptozocin-induced diabetic nephropathy in mice.\",\"authors\":\"Saja Majeed Shareef, Raghad Abdulsalam Khaleel, Taif M Maryoosh\",\"doi\":\"10.1515/dmpt-2023-0092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Diabetic nephropathy is a chief reason of mortality particularly in individuals with renal dysfunction. The current research was aimed to assess the nephroprotective portion of <i>Vaccinium oxycoccos</i> toward mice diabetic nephropathy induced by streptozotocin (STZ). <i>V. oxycoccos</i> was purchased and used for hydroalcoholic extraction.</p><p><strong>Methods: </strong>Sixty male mice were subjected to STZ-intraperitoneal injection (45 mg/kg). After diabetes induction, mice were divided into five groups of diabetic control (received only STZ), non-diabetic control (received only citrate buffer), two <i>V. oxycoccos</i> treatment (received <i>V. oxycoccos</i> extract (200 and 400 mg/kg) oral daily by gavage), and metformin treatment (received metformin (500 mg/kg) oral daily by gavage). Glucose and weight of mice were checked weekly.</p><p><strong>Results: </strong>After 28 days, the effect of <i>V. oxycoccos</i> extract on serum and urine parameters were assessed. STZ caused significant decreased in the mice body weight. Mice treated with the <i>V. oxycoccos</i> (400 mg/kg) harbored the lowest weight loss at day 28 (70.2±1.38 g). STZ caused significant increase in the mice FBS. Mice treated with the <i>V. oxycoccos</i> (400 mg/kg) harbored the lowest FBS at day 28 (189.2±1.20 mg/dL). Treatment of mice with <i>V. oxycoccos</i> (400 mg/kg) caused the lowest increase in the levels of cholesterol, HbA<sub>1c</sub> and triglycerides compared to the diabetic control mice. Compared to the diabetic control group, mice treated with <i>V. oxycoccos</i> (400 mg/kg) had the highest HDL, insulin, SOD, and GSH (p<0.05). The lowest serum BUN, CR, and UR were found in mice treated with <i>V. oxycoccos</i> (400 mg/kg). Anti-inflammatory effects of <i>V. oxycoccos</i> (400 mg/kg) was shown by the lowest TNF-α, IL-6, and TGF-β1 concentration in mice treated with <i>V. oxycoccos</i> (400 mg/kg).</p><p><strong>Conclusions: </strong>The current study disclosed that treatment with <i>V. oxycoccos</i> resulted in substantial development in the serum and urine parameters and also antioxidant and anti-inflammatory response of STZ-induced diabetic mice.</p>\",\"PeriodicalId\":11332,\"journal\":{\"name\":\"Drug metabolism and personalized therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug metabolism and personalized therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1515/dmpt-2023-0092\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug metabolism and personalized therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/dmpt-2023-0092","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

摘要

目的:糖尿病肾病是导致死亡的主要原因,尤其是对肾功能不全的个体而言。本研究旨在评估越桔对链脲佐菌素(STZ)诱导的小鼠糖尿病肾病的肾保护作用。方法:60 只雄性小鼠接受链脲佐菌素(STZ)诱导的糖尿病肾病:方法:60 只雄性小鼠腹腔注射 STZ(45 毫克/千克)。糖尿病诱导后,小鼠被分为五组,分别为糖尿病对照组(仅接受 STZ)、非糖尿病对照组(仅接受柠檬酸缓冲液)、两种土茯苓治疗组(每天灌胃口服土茯苓提取物(200 和 400 毫克/千克))和二甲双胍治疗组(每天灌胃口服二甲双胍(500 毫克/千克))。每周检测小鼠的血糖和体重:结果:28 天后,小鼠血清和尿液指标均受到影响。STZ 导致小鼠体重明显下降。在第 28 天时,使用土茯苓提取物(400 毫克/千克)治疗的小鼠体重下降最少(70.2±1.38 克)。STZ 导致小鼠 FBS 明显增加。使用氧环蛇(400 毫克/千克)治疗的小鼠在第 28 天时的 FBS 最低(189.2±1.20 毫克/分升)。与糖尿病对照组小鼠相比,牛樟芝(400 毫克/千克)对小鼠胆固醇、HbA1c 和甘油三酯水平的升高作用最小。与糖尿病对照组相比,服用土茯苓(400 毫克/千克)的小鼠具有最高的高密度脂蛋白、胰岛素、SOD 和 GSH(pV. oxycoccos (400 毫克/千克))。小鼠体内的 TNF-α、IL-6 和 TGF-β1 浓度最低,这表明了土茯苓(400 毫克/千克)的抗炎作用:目前的研究表明,使用土茯苓治疗后,STZ 诱导的糖尿病小鼠的血清和尿液参数以及抗氧化和抗炎反应均有显著改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Nephroprotective effect of cranberry (Vaccinium oxycoccos) in streptozocin-induced diabetic nephropathy in mice.

Objectives: Diabetic nephropathy is a chief reason of mortality particularly in individuals with renal dysfunction. The current research was aimed to assess the nephroprotective portion of Vaccinium oxycoccos toward mice diabetic nephropathy induced by streptozotocin (STZ). V. oxycoccos was purchased and used for hydroalcoholic extraction.

Methods: Sixty male mice were subjected to STZ-intraperitoneal injection (45 mg/kg). After diabetes induction, mice were divided into five groups of diabetic control (received only STZ), non-diabetic control (received only citrate buffer), two V. oxycoccos treatment (received V. oxycoccos extract (200 and 400 mg/kg) oral daily by gavage), and metformin treatment (received metformin (500 mg/kg) oral daily by gavage). Glucose and weight of mice were checked weekly.

Results: After 28 days, the effect of V. oxycoccos extract on serum and urine parameters were assessed. STZ caused significant decreased in the mice body weight. Mice treated with the V. oxycoccos (400 mg/kg) harbored the lowest weight loss at day 28 (70.2±1.38 g). STZ caused significant increase in the mice FBS. Mice treated with the V. oxycoccos (400 mg/kg) harbored the lowest FBS at day 28 (189.2±1.20 mg/dL). Treatment of mice with V. oxycoccos (400 mg/kg) caused the lowest increase in the levels of cholesterol, HbA1c and triglycerides compared to the diabetic control mice. Compared to the diabetic control group, mice treated with V. oxycoccos (400 mg/kg) had the highest HDL, insulin, SOD, and GSH (p<0.05). The lowest serum BUN, CR, and UR were found in mice treated with V. oxycoccos (400 mg/kg). Anti-inflammatory effects of V. oxycoccos (400 mg/kg) was shown by the lowest TNF-α, IL-6, and TGF-β1 concentration in mice treated with V. oxycoccos (400 mg/kg).

Conclusions: The current study disclosed that treatment with V. oxycoccos resulted in substantial development in the serum and urine parameters and also antioxidant and anti-inflammatory response of STZ-induced diabetic mice.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Drug metabolism and personalized therapy
Drug metabolism and personalized therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
2.30
自引率
0.00%
发文量
35
期刊介绍: Drug Metabolism and Personalized Therapy (DMPT) is a peer-reviewed journal, and is abstracted/indexed in relevant major Abstracting Services. It provides up-to-date research articles, reviews and opinion papers in the wide field of drug metabolism research, covering established, new and potential drugs, environmentally toxic chemicals, the mechanisms by which drugs may interact with each other and with biological systems, and the pharmacological and toxicological consequences of these interactions and drug metabolism and excretion. Topics: drug metabolizing enzymes, pharmacogenetics and pharmacogenomics, biochemical pharmacology, molecular pathology, clinical pharmacology, pharmacokinetics and drug-drug interactions, immunopharmacology, neuropsychopharmacology.
期刊最新文献
Pediatric pharmacogenetics: profiling CYP2C8 polymorphisms at King Abdulaziz University Dental Clinic. Unlocking the therapeutic potential and personalized therapy of testosterone: a comprehensive review. Acute and sub-chronic oral GLP toxicity of Withania somnifera root extract in Sprague Dawley rats. Acute and sub-chronic oral GLP toxicity of Withania somnifera root extract in Sprague Dawley rats. Current developments and advancements of 3-dimensional printing in personalized medication and drug screening.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1